Hepatobiliary Surgery
Hepatobiliary surgery, focuses on surgical management of diseases pertaining to the liver, pancreas, bile ducts, and gallbladder. While hepatobiliary cancers are rare, they can be very aggressive and usually require an integrated approach of multi-disciplinary specialty care. Incidence of hepatobiliary cancers is increasing globally. Although there have been improvements in cancer surveillance and relatively early access to therapy, most of these cancers present late when curative treatment options may be limited. With overall increase in average human life span globally, the incidence of these cancers continues to rise. Hepatobiliary surgeons at Texas Oncology specialize in surgical management of these cancers and provide individualized, compassionate, multi- disciplinary care in collaboration with our medical and radiation oncologists including clinical trials.
Conditions Treated
Hepatobiliary surgeons at Texas Oncology treat many conditions including:
- Liver
- Liver cancer
- Hepatocellular carcinoma
- Metastatic liver cancers (colorectal, neuroendocrine, etc.)
- Angiosarcoma and Hemangiosarcoma
- Focal nodular hyperplasia
- Hepatic adenoma
- Liver cysts and polycystic disease
- Pancreas
- Pancreatic cancer
- Pancreatic neoplasms (IPMN, mucinous cystadenoma)
- Neuroendocrine tumors (insulinoma, carcinoid tumors, glucagonoma, VIPoma, etc.)
- Pancreatic cysts and pseudocysts
- Chronic pancreatitis
- Biliary System
Treatment
Texas Oncology’s team of hepatobiliary surgeons, medical oncologists, radiation oncologists take an integrated and multidisciplinary approach to treating hepatobiliary cancers and related conditions including:
- Liver
- Ablation
- Minimally invasive and open resection
- Chemoembolization/Radioembolization
- Radiation therapy
- Chemotherapy
- Precision Cancer Medicines (Nexavar® (sorafenib), Lenvima (lenvatinib), Cabometyx (cabozantinib), Stivarga (regorafenib), Cyramza (ramucirumab)) o Checkpoint Inhibitor Immunotherapy ( Keytruda® (pembrolizumab), Opdivo (nivolumab), Imfinzi (durvalumab), Tecentriq® (atezolizumab))
- Pancreas
- Whipple procedure
- Distal pancreatectomy
- Total pancreatectomy
- Surgery for non-cancer pancreatic conditions
- Neo-adjuvant and adjuvant chemotherapy
- Radiation therapy
- Biliary System (Bile Ducts and Gallbladder)
- Minimally invasive and open resection of bile duct tumors
- Immunotherapy
Clinical Trials
Our practices participate in national clinical trials, and our research played a pivotal role in developing more than 100 of the latest FDA-approved cancer drugs. This allows eligible patients more treatment options while aiding the development of new treatments for cancer. Clinical trials for hepatobiliary surgeries are available. A hepatobiliary surgeon can determine if one is appropriate for you.
Other Resources